Zambia builds cholera vaccine plant in Lusaka
By the AFREEQUE newsroom, based on ANG and News Diggers
Zambia has begun building its first cholera vaccine plant in Lusaka, with an annual capacity of 20 million doses, to be operated by ZAMVAX Limited. Health Minister Roma Chilengi sees it as a step towards vaccine self-sufficiency, she said at the ceremony, according to ANG.
Zambia began construction of its first cholera vaccine plant in Lusaka on Tuesday 17 November. The facility, which will be operated by ZAMVAX Limited, is expected to have the capacity to produce up to 20 million doses a year, Zambian Health Minister Roma Chilengi announced at the launch ceremony, according to the Zambia News and Information Services (ANG).
The first phase of the project will focus on filling vials, packaging and quality control of oral vaccines. The necessary raw materials will be imported. According to Roma Chilengi, developing this capacity should enable the country to meet its own needs and also supply doses to regional markets.
The plant is the result of a partnership between the Industrial Development Corporation of Zambia (IDC), a state-owned company, and Chinese company Jijia International Medical Technology. The IDC will hold 60% of ZAMVAX’s capital, compared with 40% for its Chinese partner. The project also provides for technology transfer and the creation of specialised jobs.
The minister recalled that Zambia continues to face recurring cholera outbreaks. According to the World Health Organization (WHO), the 2023-2024 epidemic caused more than 700 deaths out of over 23,000 recorded cases, making it the country’s worst crisis of this kind.
The start of construction follows announcements made in November concerning the project’s financing and industrial partnership. On 2 November, Zambia presented a 213 million dollar vaccine plant project, before announcing on 7 November cooperation between Zambia and China on the anti-cholera vaccine plant.






